Chief Executive Officer
Dr. Rami Batal is the incoming CEO of Universal Ibogaine. He is a seasoned biopharmaceutical industry executive and a healthcare professional who has a passion for, and expertise and experience in, neuropsychiatry and mental health/behavioral health illnesses, including substance use disorders.
Chairman, Co Founder & Director
Shayne Nyquvest is the former Executive Vice President of Mackie Research Capital and a founding member of the Canaccord Genuity Group. Nyquvest can personally vouch for the transformational effects of ibogaine and aims to see this treatment adopted by the mainstream medical community as an answer to the opioid epidemic.
Director of Operations
Richard Avis is a senior management executive with a 30-year strong background in start-up management and franchising. He most recently operated a Vancouver-based advisory firm specializing in the growth & profitability of Startups, SMB’s, Emerging Brands and Franchised operations, including leadership mentoring, brand management, franchise compliance & marketing.
Chief Financial Officer
Greg Leavens, CPA CA - a Calgary based financial executive (past CFO and Controller roles) with 30 years experience in public accounting and industry, including the oil & gas exploration / production and service sectors. Greg started his career with KPMG, and has extensive experience in leadership, strategic planning, due diligence reviews, financing, forecasting, financial reporting, treasury and risk management, and regulatory compliance. His background includes significant roles in planning, monitoring, and executing programs to aid in achieving high profitability, growth, and success of results oriented management teams, especially in start-up, entrepreneurial environments.
Chief Nursing Advisor
Hirpal has over 30 years of health care leadership experience focused on clinical practice in high acuity settings, curriculum development and delivery for registered nurses and regularly serves the Supreme Court of B.C. as an expert on standard of care. Hirpal has worked closely with Health Canada to facilitate upcoming clinical trials for ibogaine in Canada. Hirpal is a graduate the University of British Columbia with her Master of Science in Nursing (Hons) and is certified by the Canadian Patient Safety Institute. Her recent research on critical thinking in the face of complexity has been internationally recognized. Hirpal is committed to developing more comprehensive and holistic systems of care for those suffering from addiction.
Colleen Clandening utilizes her passion to give back and her expertise in business development. A true visionary and entrepreneur. Colleen upholds the core value of “shared leadership” throughout her career. She is the CEO of Zane David Enterprises Inc. (ZDE) and former CEO of eScape MovieWorks Inc. Colleen works internationally across different sectors; entertainment, design build, retail, manufacturing, real estate, government, and non-profits. She loves her family, sharing stories with friends, laughter, vulnerability and horses. She is committed to fitness…physical, mental and spiritual.
Dr. Sue Nielsen
After many years of study, practicing yoga and meditation, and with spiritual guidance, I found a unique path to recovery. I uncovered a little-known psychedelic called Ibogaine. It reduces opioid withdrawals from weeks to months down to mere hours. It supports psychological healing. It helps the post-withdrawal period to minimize depression and relapse. After gaining back my freedom from opioid dependence, I wanted to share my experience with the rest of the world. Ibogaine represents a positive benefit in the battle against the opioid pandemic and warrants further investigation.
Resilience, Leadership, Empowerment
Theo Fleury is perhaps best known for his time on the ice. But off the rink, his life once carried the markings of a troubled childhood, abuse and coping with emotional pain through addictive and self-destructive behaviours. Today, Theo defines himself as a victor over trauma and addiction, and a facilitator to those still trying to find their way. His best-selling books, Playing with Fire and Conversations with a Rattlesnake, encourage open sharing and provide practical tools that people seeking help can personally use. These tools are also useful to those who want to lead a productive conversation, called “Real Conversations”, with anybody else experiencing trauma.
Frank Albo PhD
Dr. Frank Albo is an internationally recognized historian and a leading authority on coded language systems in art and architecture. He holds a PhD and MPhil in the history of architecture from the University of Cambridge; an MA in ancient Near Eastern languages and culture from the University of Toronto; and a BA in religious studies and anthropology from the University of Winnipeg. A two-time bestselling author, Dr. Albo has acted as a consultant for the government of Kazakhstan, the Prince’s Regeneration Trust in the UK., as well as the world's leading design firms, including Foster + Partners, BuroHappold, and Thinc Design. Dr. Albo currently doubles as a visiting professor at the universities of Winnipeg and Manitoba, where he focuses on prehistoric Indigenous studies.
Dr. Alberto Sola MD
Co-Founder & Director
Clear Sky Addiction Solution’s President, Dr Sola is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Universidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals for tourists in Puerto Vallarta, Cancun, and Cabo San Lucas.
Chief Ian Campbell MBA Director
Chief Ian Campbell is a hereditary chief of the Squamish Nation located in Vancouver, British Columbia. He has served as an elected member of council since 2005, and was appointed as a Political Spokesperson in 2008. Since 1999 he has been the Cultural Ambassador and Negotiator for the Intergovernmental Relations Department of the Squamish Nation, advancing Aboriginal rights and title, while invigorating substantive economic opportunities through negotiations, collaboration, and partnerships.
Robert Turner MBA
Mr. Turner is President of his own incorporated consulting firm and a Principal within Western Management Consultants (WMC). His consulting focus is providing guidance to Boards on their governance including proper CEO oversight. Mr. Turner brings experience as a CHRO in both the private and public sectors and Canadian health care. Robert has served on Universal Ibogaine’s Advisory Board since December 2019. Robert has an ICD.D certification from Rotman Business School, an MBA from the Ivey Business School and a BSc (Biochemistry) from the University of Toronto.